White Papers
-
Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs
10/6/2025
Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.
-
A Powerful Non-Destructive Tool For Tablet Characterization
10/6/2025
Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.
-
Achieve Higher Targeted Concentrations
9/30/2025
Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.
-
Molecular Approaches To Streamline Cell Therapy Product Analytical Testing
9/26/2025
Learn how rapid molecular methods of cell therapy testing like qPCR for mycoplasma, sterility, and lentiviral quantification are key to accelerating product release and timely treatment delivery.
-
Optimizing Charge And N-glycan Profiles For CHO-Derived Fusion Proteins
9/24/2025
Discover how structured design-of-experiment approaches can optimize charge variants and glycosylation to enhance biologics quality and therapeutic performance.
-
Developing Pulmonary Dosage Forms For Complex Molecule Delivery
9/23/2025
Discover how next-generation inhalation technologies can transform pulmonary drug delivery and unlock new therapeutic possibilities for a wide range of respiratory diseases.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
9/23/2025
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
Cell-Based Screening Assay For Cholesterol Biosynthetic Pathway Inhibition
9/17/2025
Using the RapidFire 365 HTMS platform, see how we were able to provide the sensitivity, speed, and throughput necessary to accelerate screening of large compound libraries and address challenges in oncology drug discovery.
-
Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future
9/16/2025
See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
Enabling Quality By Design
9/8/2025
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.